Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas A Saunders

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|August 5, 2010
Cisplatin treatment induces a transient increase in tumorigenic potential associated with high interleukin-6 expression in head and neck squamous cell carcinomaKim J Poth, Alexander D Guminski, Gethin P Thomas, et al.
Nucleic Acids Research|July 11, 2007
Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiationWenyi Gu, Jianmin Ding, Xiao Wang, et al.
The Journal of Investigative Dermatology|January 21, 2011
Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1Mehlika Hazar-Rethinam, Sarina R Cameron, Alison L Dahler, et al.
Experimental Dermatology|September 18, 2009
Fetuin-A promotes primary keratinocyte migration: independent of epidermal growth factor receptor signallingXue-Qing Wang, Betsy S Hung, Margit Kempf, et al.
The Journal of Investigative Dermatology|May 2, 2002
Isolation (from a basal cell carcinoma) of a functionally distinct fibroblast-like cell type that overexpresses PtchAnthony J Dicker, Magdalena M Serewko, Terry Russell, et al.
Oncogene|March 1, 2005
E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell lineChung Fai Wong, Liam M Barnes, Alison L Dahler, et al.
EMBO Molecular Medicine|June 27, 2012
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesNicholas A Saunders, Fiona Simpson, Erik W Thompson, et al.
Virology|January 22, 2010
Expression of papillomavirus L1 proteins regulated by authentic gene codon usage is favoured in G2/M-like cells in differentiating keratinocytesJianmin Ding, John Doorbar, Bo Li, et al.
Molecular Pharmacology|August 27, 2005
RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatinLisa N Putral, Megan J Bywater, Wenyi Gu, et al.
Cancer Research|July 5, 2002
Alterations in gene expression and activity during squamous cell carcinoma developmentMagdalena M Serewko, Claudia Popa, Alison L Dahler, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|August 5, 2010
Cisplatin treatment induces a transient increase in tumorigenic potential associated with high interleukin-6 expression in head and neck squamous cell carcinomaKim J Poth, Alexander D Guminski, Gethin P Thomas, et al.
Nucleic Acids Research|July 11, 2007
Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiationWenyi Gu, Jianmin Ding, Xiao Wang, et al.
The Journal of Investigative Dermatology|January 21, 2011
Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1Mehlika Hazar-Rethinam, Sarina R Cameron, Alison L Dahler, et al.
Experimental Dermatology|September 18, 2009
Fetuin-A promotes primary keratinocyte migration: independent of epidermal growth factor receptor signallingXue-Qing Wang, Betsy S Hung, Margit Kempf, et al.
The Journal of Investigative Dermatology|May 2, 2002
Isolation (from a basal cell carcinoma) of a functionally distinct fibroblast-like cell type that overexpresses PtchAnthony J Dicker, Magdalena M Serewko, Terry Russell, et al.
Oncogene|March 1, 2005
E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell lineChung Fai Wong, Liam M Barnes, Alison L Dahler, et al.
EMBO Molecular Medicine|June 27, 2012
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesNicholas A Saunders, Fiona Simpson, Erik W Thompson, et al.
Virology|January 22, 2010
Expression of papillomavirus L1 proteins regulated by authentic gene codon usage is favoured in G2/M-like cells in differentiating keratinocytesJianmin Ding, John Doorbar, Bo Li, et al.
Molecular Pharmacology|August 27, 2005
RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatinLisa N Putral, Megan J Bywater, Wenyi Gu, et al.
Cancer Research|July 5, 2002
Alterations in gene expression and activity during squamous cell carcinoma developmentMagdalena M Serewko, Claudia Popa, Alison L Dahler, et al.
Pageof 7